These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 10861039)
21. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. Michaëlsson J; Achour A; Rölle A; Kärre K J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483 [TBL] [Abstract][Full Text] [Related]
22. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Hanke T; Takizawa H; Raulet DH Eur J Immunol; 2001 Nov; 31(11):3370-9. PubMed ID: 11745355 [TBL] [Abstract][Full Text] [Related]
23. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors. Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P J Exp Med; 2001 Nov; 194(10):1519-30. PubMed ID: 11714758 [TBL] [Abstract][Full Text] [Related]
24. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Held W; Dorfman JR; Wu MF; Raulet DH Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935 [TBL] [Abstract][Full Text] [Related]
25. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Raulet DH; Held W; Correa I; Dorfman JR; Wu MF; Corral L Immunol Rev; 1997 Feb; 155():41-52. PubMed ID: 9059881 [TBL] [Abstract][Full Text] [Related]
26. Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ib-encoded target ligands. Naper C; Dai KZ; Kveberg L; Rolstad B; Niemi EC; Vaage JT; Ryan JC J Immunol; 2005 Mar; 174(5):2702-11. PubMed ID: 15728478 [TBL] [Abstract][Full Text] [Related]
27. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Roth C; Carlyle JR; Takizawa H; Raulet DH Immunity; 2000 Jul; 13(1):143-53. PubMed ID: 10933402 [TBL] [Abstract][Full Text] [Related]
28. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237 [TBL] [Abstract][Full Text] [Related]
29. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras. Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275 [TBL] [Abstract][Full Text] [Related]
30. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells. Andersson M; Freland S; Johansson MH; Wallin R; Sandberg JK; Chambers BJ; Christensson B; Lendahl U; Lemieux S; Salcedo M; Ljunggren HG J Immunol; 1998 Dec; 161(12):6475-9. PubMed ID: 9862670 [TBL] [Abstract][Full Text] [Related]
31. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets. Toomey JA; Salcedo M; Cotterill LA; Millrain MM; Chrzanowska-Lightowlers Z; Lawry J; Fraser K; Gays F; Robinson JH; Shrestha S; Dyson PJ; Brooks CG J Immunol; 1999 Sep; 163(6):3176-84. PubMed ID: 10477585 [TBL] [Abstract][Full Text] [Related]
32. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. Inngjerdingen M; Rolstad B; Ryan JC J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311 [TBL] [Abstract][Full Text] [Related]
33. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Vance RE; Jamieson AM; Cado D; Raulet DH Proc Natl Acad Sci U S A; 2002 Jan; 99(2):868-73. PubMed ID: 11782535 [TBL] [Abstract][Full Text] [Related]
34. Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. Williams NS; Moore TA; Schatzle JD; Puzanov IJ; Sivakumar PV; Zlotnik A; Bennett M; Kumar V J Exp Med; 1997 Nov; 186(9):1609-14. PubMed ID: 9348320 [TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910 [TBL] [Abstract][Full Text] [Related]
36. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Bélanger S; Tu MM; Rahim MM; Mahmoud AB; Patel R; Tai LH; Troke AD; Wilhelm BT; Landry JR; Zhu Q; Tung KS; Raulet DH; Makrigiannis AP Blood; 2012 Jul; 120(3):592-602. PubMed ID: 22661698 [TBL] [Abstract][Full Text] [Related]
37. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. Olsson-Alheim MY; Salcedo M; Ljunggren HG; Kärre K; Sentman CL J Immunol; 1997 Oct; 159(7):3189-94. PubMed ID: 9317116 [TBL] [Abstract][Full Text] [Related]
38. Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d). Silver ET; Gong D; Hazes B; Kane KP J Immunol; 2001 Feb; 166(4):2333-41. PubMed ID: 11160290 [TBL] [Abstract][Full Text] [Related]
39. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor. Lian RH; Freeman JD; Mager DL; Takei F J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224 [TBL] [Abstract][Full Text] [Related]
40. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. Held W; Cado D; Raulet DH J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]